Fundraising FoxActicor Biotech
6 known investors
Find your way into Acticor Biotech
Sign up to find every way you can get introduced to Acticor Biotech
- Your email: who you already know at Acticor Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Acticor Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI. The company is focused on cardiovascular and cerebrovascular indications.
Founders & leadership
Investors · 6
How we know: Karista's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Newton Biocapital's portfolio page · funding news · gocapital.fr · the VCSheet dataset · Not right? Tell us
How we know: gocapital.fr · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BNov 2019
Go Capital (lead), Anaxago, CapDecisif Management, Newton BioCapital
Source ↗ - Undisclosed amountSeries BOct 2018Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Acticor Biotech do?
- Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI. The company is focused on cardiovascular and cerebrovascular indications.
- Who founded Acticor Biotech?
- Acticor Biotech was founded by Gilles AVENARD.
- Who are Acticor Biotech's investors?
- Acticor Biotech's investors include Agoranov, Karista, Newton Biocapital, Anaxago, GO Capital.